Understanding Myelofibrosis: Disease Spectrum and Impact on

Aaron Gerds, MD, MS, compares myelofibrosis with other myeloproliferative neoplasms, explores its prevalence in the US, and reviews the diverse clinical presentations and the impact on patients’ quality of life.

Related Keywords

United States , Aaron Gerds , Myelofibrosis , Myeloproliferative Neoplasms , Clinical Features , Prevalence , Quality Of Life , Cytokine Mediated Symptoms , Anemia , Chronic Illness , Disease Burden , Patient Characteristics , Jak Inhibitors , Nccn Guidelines , Anemia Intervention , Momelotinib , Category Recommendations , Evidence Blocks , Symptomatic High Risk ,